The p53 pathway is impaired in most, if not all, tumors. In half of human cancers the p53 gene is mutated, and in the other half the p53 protein can be inactivated by overexpression of one of its specific inhibitors, MDM2 or MDM4.

Key publications
All publications
No news.
All news
Job offers
No job offers available.
All job offers